)
)
)
Sunhawk Vision Biotech, Inc.
Sunhawk Vision Biotech is a clinic-stage company focused on microRNA therapy for ocular diseases via eye drops instillation. The product pipelines in the late clinical stage include myopia control for pediatric subjects, recurrent corneal erosion in Sjogren's patients (RCE-SS), dry eye disease (DED) etc. DED has entered the phase-3 stage, and RCE-SS is under review for orphan drug designation after its outstanding and significant result in a phase-2 trial. The ongoing phase-2 trial for myopia control in children has completed the patient recruitment and will announce the result in Q1 2027.
No intention to meet CRO, CMO or consulting firms.
Address
TaipeiNA
Taiwan
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)